Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) AOD-9604 is a modified C-terminal fragment (residues 176191, Tyr-hGH177-191) of human growth hormone, studied for lipolytic and anti-obesity properties

Maintain mitochondria, the cells energy producer (ATP) and protector against damage from oxidative stress caused by reactive oxygen species and inflammatory proteins like cytokines.16 Acts as a cofactor for liver enzymes that metabolize and excrete xenobiotics, including drugs and heavy metals.17 Eliminates toxic substances like reactive oxygen species (ROS), free radicals, peroxides, and heavy metals.17 18 Maintain adequate levels of exogenous antioxidants vitamins C and E20,21,22 Supports DNA, protein, and cellular repair, aids immune and nerve function, transports amino acids, and promotes cell health and longevity.23 Regulates glutamate and GABA levels in the brain
The numbers of patients treated with and without AZT were 3,059 and 5,221, respectively
Early human studies by Schneider-Helmert administered 25 nanomoles per kilogram intravenously